Rx for Biotech

著者: Podcast Host Chris Leidli
  • サマリー

  • The Rx for Biotech podcast is focused on the promise of advanced therapies and the leaders across the ecosystem bringing these innovative medicines to patients in need. The podcast features interviews with the experts and industry leaders developing advanced therapies and enabling technologies including physicians, healthcare providers, patient advocates, and biopharma leaders.
    All rights reserved
    続きを読む 一部表示

あらすじ・解説

The Rx for Biotech podcast is focused on the promise of advanced therapies and the leaders across the ecosystem bringing these innovative medicines to patients in need. The podcast features interviews with the experts and industry leaders developing advanced therapies and enabling technologies including physicians, healthcare providers, patient advocates, and biopharma leaders.
All rights reserved
エピソード
  • The Future of Healthcare: Insights from the Biggest Health Tech Conference of 2024
    2024/11/12
    HLTH brings together all the ecosystem stakeholders each year to discuss the innovations that will help solve some of healthcare's biggest challenges. In this podcast episode, Noe Gutierrez, the Head of Commercial Operations at Genoplex, Inc., shares many of the key themes and insights from the biggest health tech conference of 2024.
    続きを読む 一部表示
    26 分
  • How NGGT is Pioneering the Next Wave of Gene Therapies
    2024/10/10
    Next Generation Gene Therapies is developing novel gene therapies for the treatment of many rare diseases. In this podcast episode, the company's Co-Founder and Chief Operating Officer, Guang Qu, discusses how the company's dual-functional vector tech platform is being used to target many diseases.
    続きを読む 一部表示
    40 分
  • Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker
    2024/09/18
    Immunotherapies continue to redefine treatment for many types of cancer and one of the first immunotherapies approved and used clinically as a therapeutic is Interleukin-2, or IL-2. Aulos Bioscience is an immuno-oncology company that has developed AU-007, a potential best-in-class IL-2, that improves on many of the other IL-2 products in development. In this episode, we discuss the promise of AU-007 with President and CEO, Aron Knickerbocker. Link to Interleukin-2 review article can be found here: https://www.nature.com/articles/s41587-022-01390-3
    続きを読む 一部表示
    38 分

Rx for Biotechに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。